Eastgate Biotech Corp.
ETBI - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$10.29M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $10.29 Million |
|---|---|
| Enterprise Value | $13.36 Million |
| Earnings per Share | $0 |
| Beta | 3.42 |
| Outstanding Shares | 1,111,741,360 |
Return
| Return on Equity | 80.03% |
|---|---|
| Return on Assets | -253.54% |
| Return on Invested Capital | 75.31% |
Valuation & Multiples
| P/E Ratio | -2.63 |
|---|---|
| PEG | -2.06 |
| Price to Sales | - |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | 302.89 |
| Enterprise Value to EBIT | -3.35 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.23 |
| Debt to Equity | -0.58 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Eastgate Biotech Corp.
2 employees
CEO: Rosella C. Perri
EastGate Biotech Corp. is a pharmaceutical company specializing in the production and distribution of nutraceuticals. These products are rooted in natural therapies and designed for natural absorption within the body. The firm employs cu...